MindBio’s LSD-based drug reduced depression symptoms in Phase IIa trial

MindBio’s LSD-based drug reduced depression symptoms in Phase IIa trial

Submitted by admin on June 20, 2024 - 11:32am
Source: 
Clinical Trials Arena
News Tags: 
MindBio Therapeutics
clinical trials
LSD
depression
MB22001
Headline: 
MindBio’s LSD-based drug reduced depression symptoms in Phase IIa trial
snippet: 

MindBio has announced positive Phase IIa data showing that its LSD-based drug was effective in treating symptoms of depression.

Do Not Allow Advertisers to Use My Personal information